Lataa...
Exposure to antimuscarinic medications for treatment of overactive bladder and risk of lung cancer and colon cancer
INTRODUCTION: One out of six adults has symptoms of overactive bladder (OAB). Antimuscarinic medication is the main pharmacological group used in the treatment of OAB. In preclinical studies, antimuscarinic compounds have been found to inhibit cell proliferation in lung cancer and colon cancer. OBJE...
Tallennettuna:
| Julkaisussa: | Clin Epidemiol |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6350836/ https://ncbi.nlm.nih.gov/pubmed/30774448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CLEP.S186842 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|